Last reviewed · How we verify
Enema
At a glance
| Generic name | Enema |
|---|---|
| Also known as | Fleets enema, Placebo arm |
| Sponsor | Methodist Health System |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | discontinued |
Approved indications
Common side effects
Key clinical trials
- The Correlation of Surgical Colorectal Cancer Specimen Pathology With the Fluorescence of Photodynamic Diagnostics (PDD): a Clinical Pilot Study (Phase 2)
- Fecal Microbiota Transplant for Recurrent Clostridium Difficile Infection (N/A)
- Investigating the Necessity of Bowel Preparation in Minimally Invasive Gynecologic Surgery (NA)
- Fecal Microbial Transplantation in Relapsing Multiple Sclerosis Patients (Phase 2)
- Retrograde Colonic Irrigation to Manage Spina Bifida Functional Digestive Sequelae: a Multicenter, Prospective, Randomized Controlled Trial (NA)
- Fecal Microbiota Transplant in Veterans With Cirrhosis (Phase 1)
- A Prospective Single Center Open Label Trial of RBX2660 (Microbiota Suspension) in the Management of Hepatic Encephalopathy (Phase 1)
- BioXmark Liquid Fiducials to Enable Radiotherapy Tumor Boosting in Rectal Cancer, a Feasibility Trial (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Enema CI brief — competitive landscape report
- Enema updates RSS · CI watch RSS
- Methodist Health System portfolio CI